Introduction: Nitazenes are potent synthetic opioids and N-desethyl isotonitazene, a metabolite of isotonitazene, has emerged as a drug in its own right.
Methods: This is an observational case series of patients with suspected or declared substance use who were admitted to hospitals in the Sandwell and West Birmingham National Health Service Trust between July and October 2023. All patients were found on toxicological screening to have been exposed to N-desethyl isotonitazene.
Results: Twenty presentations involving 19 patients who tested positive for N-desethyl isotonitazene were included in the study. In 19 presentations, multiple substances were detected on toxicological screening. The number of patients testing positive for other substances were: 19 for cocaine and its main metabolite benzoylecgonine, 13 for morphine, 11 for the heroin-specific metabolite 6-monoacetylmorphine, ten for xylazine, eight for gabapentinoids (pregabalin and/or gabapentin), seven for methadone and/or the metabolite, 2-ethylidene-1, 5-dimethyl-3, 3-diphenylpyrrolidine, six for benzodiazepines and five for the synthetic cannabinoid MDMB-4en-PINACA. Only one patient had no other substances detected apart from N-desethyl isotonitazene. This patient presented with coma, miosis, bradypnoea and hypercapnia and responded to naloxone. In this cohort, the median concentration of N-desethyl isotonitazene was 1.53 µg/L ( = 14; range 0.59-5.48) in whole blood and 27.75 µg/L ( = 16; range 0.51-91.53) in urine.
Discussion: The majority of the patients in this cohort presented with features typical of an opioid overdose, which is unsurprising as they were all experienced users of diamorphine. Although these features are also consistent with the known effects of N-desethyl isotonitazene, in only one case is it possible to attribute the patient's features to N-desethyl isotonitazene toxicity alone.
Conclusions: This case series highlights the need for toxicovigilance in the illicit drug market as patterns of substance misuse evolve and novel psychoactive substances continue to emerge.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/15563650.2024.2309321 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Metabolism of Six Novel Nitazenes in Human Liver Microsomes Based on Ultra-High-Performance Liquid Chromatography Coupled With High-Resolution Mass Spectrometry.
Drug Test Anal
December 2024
School of Pharmacy, China Pharmaceutical University, Nanjing, China.
Synthetic opioids are a chemically diverse group of substances that function as central nervous system depressants, among which the 2-benzylbenzimidazole derivatives, also known as nitazenes or nitazene analogs, have recently emerged into the recreational market. The detection of these substances in biological samples largely relies on the acquisition of metabolic data. In this study, the first-phase metabolism patterns of methylenedioxynitazene, N-desethyl etonitazene, N-desethyl methylenedioxynitazene, ethyleneoxynitazene, N-pyrrolidino etonitazene, and N-desethyl isotonitazene utilizing human liver microsomes were investigated, and the metabolites were characterized through high-performance liquid chromatography-high-resolution tandem mass spectrometry.
View Article and Find Full Text PDFDetection of N-desethyl etonitazene in a drug checking sample: Chemical analysis and pharmacological characterization of a recent member of the 2-benzylbenzimidazole "nitazene" class.
J Pharm Biomed Anal
December 2024
Institute of Forensic Medicine, Department of Biomedical Engineering, University of Basel, Basel, Switzerland.
The emergence of 2-benzylbenzimidazole "nitazene" opioids is stirring up the recreational synthetic opioid market. Many nitazene analogues act as potent agonists at the µ‑opioid receptor (MOR), as demonstrated in various in vitro and in vivo studies. Severe intoxication and overdose deaths associated with nitazene analogues are increasingly being reported.
View Article and Find Full Text PDFIn vitro structure-activity relationships and forensic case series of emerging 2-benzylbenzimidazole 'nitazene' opioids.
Arch Toxicol
September 2024
Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.
2-Benzylbenzimidazole 'nitazene' opioids are presenting a growing threat to public health. Although various nitazenes were previously studied, systematic comparisons of the effects of different structural modifications to the 2-benzylbenzimidazole core structure on μ-opioid receptor (MOR) activity are limited. Here, we assessed in vitro structure-activity relationships of 9 previously uncharacterized nitazenes alongside known structural analogues.
View Article and Find Full Text PDFPharmacologic Characterization of Substituted Nitazenes at , , and Opioid Receptors Suggests High Potential for Toxicity.
J Pharmacol Exp Ther
April 2024
VA Portland Health Care System (L.B.K., A.J.E., K.M.W., T.L.S., S.H.B., S.B., J.L.S., K.A.S., W.E.S., A.J., A.I.A.), Departments of Psychiatry (L.B.K., A.J.E., T.L.S., W.E.S., A.J., A.I.A.), and Behavioral Neuroscience (L.B.K., A.J., A.I.A.), Oregon Health and Science University, Portland, Oregon
The benzimidazole opioids (substituted nitazenes) are highly potent opiod receptor (MOR) agonists with heroin- or fentanyl-like effects. These compounds have caused hospitalizations and fatal overdoses. We characterized the in vitro pharmacology and structure-activity relationships of 19 nitazenes with substitutions at three positions of the benzimidazole core.
View Article and Find Full Text PDFN-desethyl isotonitazene detected in polydrug users admitted to hospital in Birmingham, United Kingdom.
Clin Toxicol (Phila)
January 2024
Toxicology Laboratory, Sandwell and West Birmingham NHS Trust, Birmingham, UK.
Introduction: Nitazenes are potent synthetic opioids and N-desethyl isotonitazene, a metabolite of isotonitazene, has emerged as a drug in its own right.
Methods: This is an observational case series of patients with suspected or declared substance use who were admitted to hospitals in the Sandwell and West Birmingham National Health Service Trust between July and October 2023. All patients were found on toxicological screening to have been exposed to N-desethyl isotonitazene.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!